Results 21 to 30 of about 57,560 (274)

Levofloxacin-based therapy as an efficient alternative for eradicating Helicobacter pylori infection in Iran: a systematic review and meta-analysis

Journal of Global Antimicrobial Resistance, 2022
: Objectives: Despite excessive resistance of Helicobacter pylori to clarithromycin among the Iranian population, clarithromycin-based therapy is still prescribed in Iran. Recent studies have shown high rates of H. pylori eradication in patients treated
Masoud Keikha, Parvin Askari, Kiarash Ghazvini, Mohsen Karbalaei   +3 more
doaj   +1 more source

Clinical Evaluation of a Real-Time PCR Assay for Simultaneous Detection of Helicobacter pylori and Genotypic Markers of Clarithromycin Resistance Directly from Stool

Journal of Clinical Microbiology, 2021
Helicobacter pylori infection is mainly diagnosed noninvasively, with susceptibility testing traditionally requiring endoscopy. Treatment is empirical, with clarithromycin-based triple therapy recommended where resistance rates are below 15%.
Rebecca Marrero Rólon, S. Cunningham, J. Mandrekar, Erin T. Polo, Robin Patel   +4 more
semanticscholar   +1 more source

A nationwide cohort study suggests clarithromycin-based therapy for Helicobacter pylori eradication is safe in patients with stable coronary heart disease and subsequent peptic ulcer disease

BMC Gastroenterology, 2022
Background Clarithromycin-based therapy is important for Helicobacter pylori eradication treatment. However, clarithromycin may increase cardiovascular risk.
Yen-Chun Chen, Yi-Da Li, Ben-Hui Yu, Yi-Chun Chen   +3 more
doaj   +1 more source

eradication and clarithromycin resistance [PDF]

, 2023
Background: Clarithromycin resistance of Helicobacter pylori (H. pylori) represents a major challenge in eradication therapy. In this study, we assessed if non-invasive stool tests can be used to verify successful H.
Gwenny M. Fuhler, Manon C. W. Spaander, Mommersteeg, Michiel C., Roovers, Buddy H.C.M., Kuipers, Ernst J., Stella A. V. Nieuwenburg, Maikel P. Peppelenbosch, Auke P. Verhaar, Buddy H. C. M. Roovers, Spaander, Manon C.W., Ernst J. Kuipers, Hanneke A. J. van Vuuren, Marco J. Bruno, Nieuwenburg, Stella A.V., Leonieke M. M. Wolters, Wolters, Leonieke M.M., Peppelenbosch, Maikel P., van Vuuren, Hanneke A.J., Fuhler, Gwenny M., Bruno, Marco J., Michiel C. Mommersteeg, Verhaar, Auke P.   +21 more
core   +1 more source

Anti-Helicobacter pylori Effects of Propolis Ethanol Extract on Clarithromycin and Metronidazole Resistant Strains [PDF]

, 2020
Antimicrobial resistance for Helicobacter pylori infection still become problem in Indonesia especially for metronidazole and clarithromycin resistance that is commonly used in the national regiment therapy. Finding a new antimicrobial agent against this
Ari Fahrial Syam, Dalla Doohan, Ariel Panjaitan, Diah Priyantini, Muhammad Miftahussurur, Yoshio Yamaoka, Yobella Priskila, Kartika Afrida Fauzia, I Ketut Adnyana, Elin Yulinah, Ricky Indra Alfaray, Yudith Annisa Ayu Rezkitha, Ali Khomsan, Neneng Ratnasari, Langgeng Agung Waskito   +14 more
core   +1 more source

Genetic Evolution of Mycobacterium abscessus Conferring Clarithromycin Resistance during Long-Term Antibiotic Therapy

Canadian Respiratory Journal, 2020
Objectives. Clarithromycin is recommended as the core agent for treating M. abscessus infections, which usually calls for at least one year of treatment course, facilitating the development of resistance.
Bing Li, Qi Guo, Yanhua Mao, Yuzhen Zou, Yongjie Zhang, Zhemin Zhang, Haiqing Chu   +6 more
doaj   +1 more source

Time-dependent effect of clarithromycin on pro-inflammatory cytokines in CRS [PDF]

Rhinology Online, 2022
Background: The purpose of this study was to assess the time-effect of clarithromycin on the inflammatory response in chronic rhinosinusitis (CRS), to further explore the use of macrolides in cell culture as a model for CRS, and its action on the immune ...
Ana Catarina Pratas, Zara Shaida, Jelena Gavrilovic, Carl Philpott   +3 more
doaj   +1 more source

Pattern of Primary Resistance of Helicobacter pylori to Clarithromycin among Pediatric Patients from North-Eastern Romania

Children, 2023
Background: Helicobacter pylori antibiotic resistance has increased worldwide and affects the effectiveness of current therapies. The recommended first-line empiric treatment should be tailored to the local clarithromycin resistance rate.
Oana-Maria Rosu, Nicoleta Gimiga, Roxana Popescu, Ileana Ioniuc, Carmen Daniela Rusu, Tatiana Clipa, Diana-Maria Florea, Doina-Anca Pleșca, Alexandru Nemtoi, Elena Tataranu, Gabriela Stefanescu, Smaranda Diaconescu   +11 more
doaj   +1 more source

Diagnostic Accuracy of a Noninvasive Test for Detection of Helicobacter pylori and Resistance to Clarithromycin in Stool by the Amplidiag H. pylori+ClariR Real-Time PCR Assay

Journal of Clinical Microbiology, 2020
The noninvasive detection of Helicobacter pylori and its resistance to clarithromycin could revolutionize the management of H. pylori-infected patients by tailoring eradication treatment without any need for endoscopy when histology is not necessary ...
M. Pichon, Benoit Pichard, T. Barrioz, C. Plouzeau, V. Croquet, Ginette Fotsing, Alexandre Chéron, É. Vuillemin, M. Wangermez, P. Haineaux, Philippe Vasseur, Q. Thiebault, C. Lefevre, A. de Singly, J. Cremniter, Lauranne Broutin, A. Michaud, C. Silvain, C. Burucoa   +18 more
semanticscholar   +1 more source

Trends in Helicobacter pylori resistance to clarithromycin: from phenotypic to genomic approaches

Microbial Genomics, 2020
For a long time Helicobacter pylori infections have been treated using the macrolide antibiotic, clarithromycin. Clarithromycin resistance is increasing worldwide and is the most common cause of H. pylori treatment failure.
A. T. Marques, Jorge M. B. Vítor, Andrea Santos, M. Oleastro, F. F. Vale   +4 more
semanticscholar   +1 more source